Guardant Health (GH) Capital Expenditures (2017 - 2026)

Guardant Health (GH) has 10 years of Capital Expenditures data on file, last reported at $5.6 million in Q1 2026.

• Quarterly Capital Expenditures rose 25.14% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.4 million (up 51.57% YoY) and the FY2025 annual result came in at $48.3 million, up 37.68% from the prior year.
• Capital Expenditures declined to $5.6 million in Q1 2026 per GH's latest filing, from $27.8 million in the prior quarter.
• The five-year high for Capital Expenditures was $50.6 million in Q3 2022, with the low at -$11.1 million in Q4 2023.
• Average Capital Expenditures over 5 years is $10.1 million, with a median of $6.0 million recorded in 2023.
• Year-over-year, Capital Expenditures surged 285.99% in 2022 and plunged 211.29% in 2023.
• Guardant Health's Capital Expenditures stood at $10.0 million in 2022, then sank by 211.29% to -$11.1 million in 2023, then soared by 269.59% to $18.9 million in 2024, then surged by 47.54% to $27.8 million in 2025, then slumped by 79.96% to $5.6 million in 2026.
• Business Quant data shows GH's Capital Expenditures at $5.6 million in Q1 2026, $27.8 million in Q4 2025, and $10.4 million in Q3 2025.